We are live on
!
Find out more
WT
Wellcome Trust Portfolio holdings
AUM
$9.01B
1-Year Est. Return
12.05%
This Fund
S&P 500
This Quarter
Est. Return
+3.08%
1 Year Est. Return
+12.05%
3 Year Est. Return
+59.66%
5 Year Est. Return
+58.12%
10 Year Est. Return
+403.84%
AUM
$4.15B
AUM Growth
+$89.2M
(+2.2%)
Cap. Flow
+$19.2M
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
55.78%
Holding
40
New
4
Increased
4
Reduced
4
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
+$15.9M |
| 2 |
Bank of America
BAC
|
+$7.77M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$1.6M |
| 4 |
Cisco
CSCO
|
+$1.19M |
| 5 |
Apple
AAPL
|
+$426K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
+$7.17M |
| 2 |
Visa
V
|
+$1.75M |
| 3 |
Verizon
VZ
|
+$1.45M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.25M |
| 5 |
Meta Platforms (Facebook)
META
|
+$953K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.13% |
| 2 | Technology | 23.86% |
| 3 | Communication Services | 19.25% |
| 4 | Consumer Staples | 11.38% |
| 5 | Energy | 7.98% |
Similar funds
A
VAS
AI
AI
HI
SFM
MIH
RWP
Wellcome Trust's Q2 2014 Portfolio in Review
As of Q2 2014, Wellcome Trust held 40 positions worth $4.15B, up 2.2% from $4.06B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Wellcome Trust's Q2 2014 filing shows 4 new, 4 increased, 4 reduced and 9 closed positions. Its largest new stake was Radius Health, Inc.: 1,726,841 shares worth $22.4M. The largest sale was Five Prime Therapeutics, Inc., an estimated $7.17M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Communication Services.
- Wellcome Trust's largest Q2 2014 buy was Radius Health, Inc.: 1,726,841 shares worth $22.4M.
- Wellcome Trust added most to Bank of America in Q2 2014, an estimated $7.77M increase.
- Wellcome Trust's biggest Q2 2014 reduction was Verizon, cutting an estimated $1.45M.
- Wellcome Trust fully exited Five Prime Therapeutics, Inc. in Q2 2014, selling an estimated $7.17M.
- Wellcome Trust's ten largest holdings make up 56% of its $4.15B portfolio in Q2 2014.
- Wellcome Trust opened 4 new positions and closed 9 in Q2 2014.
- Wellcome Trust's portfolio value rose 2.2% quarter-over-quarter to $4.15B.
Based on Wellcome Trust's 13F filing for Q2 2014, filed 23 Jul 2014.